WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the opening of its new Doe & Ingalls Northeast cGMP chemical distribution facility to meet the growing demand for quality compliance, production chemical storage and supply chain services for the biopharmaceutical, life science and advanced technology markets.
cGMP refers to the Current Good Manufacturing Practice regulations enforced by the US Food and Drug Administration (FDA) to assure proper design, monitoring, and control of manufacturing processes and facilities.
“A secure, robust supply chain is crucial for manufacturers to remain competitive, reduce total cost of ownership and mitigate risk of supply interruption,” said Jeff Jochims, president, research and safety markets, Thermo Fisher Scientific. “Our new Doe & Ingalls facility offers customers the ability to ramp up or expand their production capabilities quickly and cost-efficiently. By leveraging our scale and depth of capabilities in production materials supply chain, our customers can focus their internal resources on what they do best -- developing new pharmaceuticals and technologies.”
Located in Peabody, Mass., the 56,000 square foot, state-of-the-art facility is designed to protect raw material integrity, control the flow of goods and deliver supply chain services. The facility is cGMP-compliant to assure products and processes are in strict compliance with regulatory agencies and meet and/or exceed standards for temperature control, audit log/documentation and product handling/sampling. Innovative supply chain services include:
- Storage and warehousing of chemical and raw materials
- Dip tube exchange and temperature-controlled 2-8°C cold storage
- ISO Class 8 and Class 100 cleanrooms provide sampling services for sourcing and quality control (QC) testing of production chemical materials
“We welcome and celebrate this expansion,” said Massachusetts Governor Deval Patrick. “This facility underscores Thermo Fisher’s commitment to the leading life sciences supercluster in the world.”
“We congratulate Thermo Fisher on the opening of the Doe & Ingalls site,” said Robert K. Coughlin, president and chief executive officer of MassBio, a life sciences trade organization. “This site will be an excellent resource for our members, many of whom are challenged to operate as a GMP-compliant operation when it’s time to scale up to pilot manufacturing. This facility will provide critical services to get them up and running, shortening the time it takes to get new products to market and to the patients who need them.”
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $17 billion and 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Our four premier brands – Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services – offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.